Microbiome Therapeutics

Biotechnology company MicroBiome Therapeutics, LLC develops medical foods and drugs. The company focuses on developing evidence-based microbiome modulators, which are designed to alter the bacterial populations and their environment in the gastrointestinal tract in specific ways to treat and prevent serious health conditions. Its products include NM504, a formulation containing a combination of prebiotics and other natural ingredients intended to help individuals with diabetes achieve healthy blood sugar levels and manage their weight. MicroBiome Therapeutics, LLC was previously known as NuMe Health LLC. The company was founded in 2009 and is headquartered in Broomfield, Colorado.